Bill Text: NJ A1546 | 2018-2019 | Regular Session | Introduced


Bill Title: Allows pharmacies to make self-administered hormonal contraceptives available over the counter.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced) 2018-01-09 - Introduced, Referred to Assembly Health and Senior Services Committee [A1546 Detail]

Download: New_Jersey-2018-A1546-Introduced.html

ASSEMBLY, No. 1546

STATE OF NEW JERSEY

218th LEGISLATURE

 

PRE-FILED FOR INTRODUCTION IN THE 2018 SESSION

 


 

Sponsored by:

Assemblyman  MICHAEL PATRICK CARROLL

District 25 (Morris and Somerset)

 

 

 

 

SYNOPSIS

     Allows pharmacies to make self-administered hormonal contraceptives available over the counter.

 

CURRENT VERSION OF TEXT

     Introduced Pending Technical Review by Legislative Counsel.

  


An Act concerning contraceptives and supplementing P.L.2003, c.280 (C.45:14-40 et seq.).

 

     Be It Enacted by the Senate and General Assembly of the State of New Jersey:

 

     1.    a. Notwithstanding any other law to the contrary, a pharmacist may furnish self-administered hormonal contraceptives in accordance with rules and regulations that shall be developed and adopted by the New Jersey State Board of Pharmacy in consultation with the State Board of Medical Examiners, and with consideration given to the guidelines established by the American Congress of Obstetricians and Gynecologists.

     b.    The New Jersey State Board of Pharmacy shall adopt rules and regulations pursuant to the "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.) to establish standard procedures for the furnishing of self-administered hormonal contraceptives by pharmacists.  The procedures shall include:

     (1)   a description of the types of contraceptives that shall be defined to be self-administered hormonal contraceptives;

     (2)   a requirement that in order to receive a self-administered hormonal contraceptive, the patient shall use a self-screening tool that identifies patient risk factors for the use of self-administered hormonal contraceptives, based on the current United States Medical Eligibility Criteria (US MEC) for Contraceptive Use developed by the federal Centers for Disease Control and Prevention; and

     (3)   a requirement that upon furnishing a self-administered hormonal contraceptive, the pharmacist shall refer the patient to the patient's primary care provider or to an appropriate medical clinic.

 

     2.    This act shall take effect on the 90th day after the date of enactment.

 

 

STATEMENT

 

     This bill allows pharmacists to furnish self-administered hormonal contraceptives in accordance with rules and regulations that are to be developed and adopted by the New Jersey State Board of Pharmacy in consultation with the State Board of Medical Examiners, and with consideration given to the guidelines established by the American Congress of Obstetricians and Gynecologists.

     The bill requires the New Jersey State Board of Pharmacy to adopt rules and regulations pursuant to the "Administrative Procedure Act" to establish standard procedures for the furnishing of self-administered hormonal contraceptives by pharmacists. The procedures are to include: (1) a description of the types of contraceptives that will be defined to be self-administered hormonal contraceptives; (2) a requirement that in order to receive a self-administered hormonal contraceptive, the patient first use a self-screening tool that identifies patient risk factors for the use of self-administered hormonal contraceptives, based on the current United States Medical Eligibility Criteria (US MEC) for Contraceptive Use developed by the federal Centers for Disease Control and Prevention; and (3) a requirement that upon furnishing a self-administered hormonal contraceptive, the pharmacist shall refer the patient to the patient's primary care provider or to an appropriate medical clinic.

feedback